Selling Digital Health Technology to Medicaid
Updated: Sep 23
Medicaid Sales Strategy Starts With the State Behind the Health Plan
Medicaid is often described as one market. In practice, it is a collection of state programs with different benefits, populations, waivers, procurement rules, managed-care structures, quality priorities, and funding dynamics. A strategy that works in one state may be irrelevant in another.
For digital health companies, the complexity is not a reason to stay away. It is the basis of the commercial opportunity. The organizations that understand how a state defines value can help managed care organizations compete, perform, and serve members more effectively. The central rule is simple. When selling to a Medicaid plan, understand the state is the plan’s customer.
Follow the funding and population before choosing a buyer
A state market should be evaluated through several layers. Enrollment shows the potential scale. The proportion of members in managed care indicates how much of that scale is addressable through health plans. Benefit design, waivers, and carve-outs reveal where services are funded and which entities control decisions.
Population characteristics matter because Medicaid spending is concentrated in distinct rate cells and needs. Children, pregnant members, adults covered through expansion, people with disabilities, individuals receiving long-term services and supports, and dual-eligible members can have different benefit structures and economics. Specialty plans for serious mental illness or substance use may create additional pathways.
A product should identify the population it changes, not merely the total Medicaid enrollment. The addressable market is the number of members for whom the intervention is relevant, covered, and reachable through the target organization.
Funding should be mapped with equal care. Federal and state contributions vary, and waivers can support specific health-related social needs or service models. Current political and budget conditions may affect which programs expand, pause, or face scrutiny. A company should monitor those changes without building its entire strategy on a temporary funding stream.
Read the state’s RFP as a strategy document
Managed care organizations win Medicaid business through state procurements. Requests for proposals describe the populations, services, performance standards, reporting, priorities, and evaluation criteria that plans must address. For a startup, these documents offer direct market intelligence.
An RFP can show which issues carry the greatest weight, how the state evaluates health equity and quality, what implementation timeline applies, and which commitments may differentiate a bidder. The vendor can then position its solution as an asset that helps the plan win or execute the contract.
This timing is something to keep an eye on. A plan preparing a bid may need partners months before an award. The vendor may have to contribute content, implementation assumptions, pricing, and evidence without any guarantee that the plan will win. Companies need sufficient capital and a deliberate approach to those pre-award investments.
After awards are announced, the market changes. Losing bidders may no longer be near-term prospects in that state, while winning plans move into implementation and need partners that can deliver. Tracking procurement creates a more efficient pipeline than treating every Medicaid plan as continuously available.
Prioritize plans where the solution can move a visible number
CMS and NCQA data can help identify plan performance, enrollment, and measure-level gaps. A company should look for the intersection of need and scale. That is, a relevant quality deficit, enough affected members, and an intervention capable of changing the result.
The webinar uses maternal health as an example. A solution supporting childcare, transportation, or navigation might affect postpartum care, well-child visits, developmental screening, or immunization measures. Plans performing poorly on the relevant measures may have stronger urgency than high-performing organizations with little room to improve.
The value proposition should be plan-specific. Instead of saying the product improves engagement, define the population, action, measure, and target: increase completion of a particular screening by a stated amount in a defined period. Specificity gives the payer a basis for evaluating the pilot and showing value to the state.
Public data should be supplemented with local research. Provider access, rural geography, language, community trust, and state policy can explain why performance differs. The technology must fit the reason for the gap.
Build the narrative around the plan’s income statement
Managed care organizations evaluate solutions through both revenue and cost. Revenue opportunities can attract attention because the upside may be less constrained than a cost-saving claim. Quality incentives, risk-adjusted payment, contract performance, and successful rebids can all contribute.
Cost reduction remains important, but the company should identify the specific utilization or administrative category it can change. Broad promises to lower total cost of care are difficult to attribute. A focused claim about avoidable emergency use, inpatient admissions, outreach efficiency, or completion of a required process is easier to test.
The business case should also include implementation cost and operational risk. Medicaid member communications can be highly regulated. Plans may rely on providers or community organizations to deploy the solution. Data may be incomplete, and member contact information can change frequently. These realities belong in the commercial model.
The strongest narrative connects four elements: the state’s benefit and procurement priorities, the plan’s population and performance gap, the product’s specific mechanism, and the financial or strategic effect.
Arrive with the pilot already designed
Undefined success is a common deal killer. A company that asks the payer to invent the target population, workflow, metrics, and price creates more work for every internal stakeholder.
A pilot proposal should specify eligibility, geography, duration, volume, member identification, outreach, provider involvement, data exchange, implementation responsibilities, pricing, metrics, evaluation, and the decision that follows. FAQs and training materials can answer likely questions from clinical, finance, quality, operations, providers, and member-service teams.
The metrics should be meaningful and controllable. Engagement may be useful as an operating indicator, but a concrete behavior, like completed screening, attended postpartum visit, successful referral, or reduction in a defined event, creates a clearer performance standard.
Technology and security expectations should be addressed in proportion to the target. National plans may expect SOC 2, HITRUST, and mature integration capabilities. Smaller local plans may have a different threshold, although privacy and security remain essential. The company should know the requirements before entering a late-stage deal.
Protect the company while pursuing distribution
Medicaid distribution can be powerful. A plan relationship may open access to a large member population and create credibility in other states. It can also create concentration and exclusivity risk.
The webinar describes a company that entered a three-year exclusive arrangement with one payer. The contract produced a customer but limited the ability to sell to other managed care organizations, reducing strategic flexibility. Founders should examine geography, population, line of business, duration, performance conditions, and termination rights before accepting exclusivity.
Pre-award RFP work creates another form of concentration. A vendor may invest heavily in one bidder that ultimately loses. A disciplined pipeline spreads risk across states, procurement stages, and buyer types while remaining focused enough to execute.
Capital strategy should reflect the sales cycle. Medicaid opportunities can be large but slow, and the vendor may need to fund security, implementation, evidence, and procurement support before revenue begins. Growth assumptions should account for the timing and probability of awards.
Use providers to build evidence, not to avoid the market
Provider partnerships can help a digital health company reach members, refine workflows, and generate peer-reviewed or real-world evidence. They are especially useful when the plan wants proof that the intervention can operate in care delivery.
Selling provider by provider, however, may require similar effort for smaller contracts and limited distribution. The appropriate route depends on who controls the budget and implementation. For many Medicaid solutions, the state or managed care organization offers the strongest path to scale, while providers serve as clinical and evidence partners.
Direct state opportunities require basic readiness. Companies should register on relevant procurement portals, monitor solicitations, and understand vendor requirements before an RFP appears. Waiting until the opportunity is posted compresses the time available to build partnerships and respond.
Medicaid rewards specificity and endurance
The market is complex because the product must fit a state program, a managed care business, a provider network, and members whose lives may make engagement difficult. Generic payer messaging will not survive that complexity.
A durable Medicaid strategy chooses a population, studies the state, reads the procurement, identifies a plan-level performance gap, and proposes a measurable pilot. It protects capital and avoids unnecessary exclusivity while building the security, evidence, and operational capabilities required for scale.
The state remains central to the process. When the company understands what the state will fund, measure, and reward, it can show the health plan how the technology helps serve the member and win the business at the same time.
About the Speakers
Shalen De Silva, MPH
Managed Care Operator
Shalen is an operator and leader in Medicare Advantage and Medicaid managed care who helps healthcare companies commercialize solutions for government-sponsored populations. His work spans Medicaid waivers, procurement, quality initiatives, supplemental benefits, payer partnerships, company building, and product strategy. Connect with Shalen on LinkedIn.
Demi Radeva, MSc
Founder and Chief Strategist at Akros Advisory
Demi has more than a decade of experience across Medicaid, Medicare, and Commercial health plans, including leadership roles at UnitedHealthcare and Optum. She now advises HealthTech companies on reimbursement, payer strategy, market access, and commercialization. Connect with Demi on LinkedIn.
Comments